Objective To establish a mouse model which can produce hepatitis C virus(HCV) RNA for examination of the efficiency of virus clearance of high-affinity HCV monoclonal antibody in vivo.Methods Huh7-Jc1 cell model was established by transfecting a genotype 2a HCV plasmid Jc1 into Huh7 cell line which can produce HCV RNA in vitro.The Huh7-Jc1 cell was injected into the nude mouse abdominally or intravenously and/,and the remaining HCV RNA level was detected by optical in vivo imaging and virus RNA in peripheral blood was also detected.Negative control was established by injecting non-HCV Huh7 cell.Results A HCV cell model was estabished which could express HCV RNA and core protein.and the supernatant of the HCV cell model also had the ability to infect the Huh7 cells.And the HCV RNA could be detected in the serum of the BALB/c-nu nude mouse which were implanted with Huh7-Jc1 cell(intraperitoneal or tail intravenous).Conclusion Our data indicates that implanting Huh7-Jc1 cell is a feasible method for building a HCV expressing mouse model,however,a higher efficiency and long-term virus producing mouse model still needed moreresearch.
[1]Sarbah SA,Younossi ZM.Hepatitis C:an update on the silent epidemic[J].J Clin Gastroenterol,2000,30(2):125-143.
|
[2]Hu YW,Rocheleau L,Larke B,et al.Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2[J].Virology,2005,332(2):538-549.
|
[3]Tarr AW,Owsianka AM,Timms JM,et al.Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33[J].Hepatology,2006,43(3):592-601.
|
[4]Tokushige K,Wakita T,Pachuk C,et a1.Expression and lmmume Response to Hepatitis C Virus Core DNA—Base Vaccine Constructs[J].Hepatology,1996,24(1):l4-20.
|
[5]Guévin C,Lamarre A,LabontéP.Novel HCV replication mouse model using human hepatocellular carcinoma xenografts[J].Antiviral Res,2009,84(1):14-22.
|
[6]Lindenbach BD,Evan MJ,Syder AJ,et al.Complete replication of hepatitis C virus in cell culture[J].Science,2005,309(5734):623-626.
|
[7]Zhu N,Ware CF,Lai MM.Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor[J].Virology,2001,283(2):178-187.
|
[8]Chou AH,Tsai HF,Wu YY,et al.Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway[J].J Immunol,2005,174:2160-2166.
|
[1] | Chen Hao, Hao JianHeng, Li ZhenCheng, Xu HuiChao, Gao Yan, Miao YuChuan, Hao HuiQin, Liu Yang. Screening for differentially expressed genes in mice with autoimmune hepatitis and effect of saikosaponin-d on the expression of several differentially expressed genes[J]. Journal of Clinical Hepatology, 2020, 36(4): 840-846. doi: 10.3969/j.issn.1001-5256.2020.04.026 |
[2] | Shi HaiYan, Li LiYa, He HaoLan, Liu HuiYuan, Chen ZhiMin, Chen WeiLie, Liao BaoLin. Association of HBV precore/core promoter variants with the degree of liver fibrosis in patients with HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(5): 1020-1024. doi: 10.3969/j.issn.1001-5256.2018.05.019 |
[3] | Zhou LianLian, Shen Mo, Zhou Ping, Zhou Wu, Lin XiangYang. HBV genotype distribution and its relationship with serum HBV DNA level and HBeAg expression among patients with chronic hepatitis B in southern Zhejiang Province, China[J]. Journal of Clinical Hepatology, 2014, 30(10): 1039-1041. doi: 10.3969/j.issn.1001-5256.2014.10.016 |
[4] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
[5] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
[6] | Guo XinHui, Yan Yan, Li Zhuo, Yin JiMing. Fluorescent reverse transcription-PCR assay for determination of hepatitis C virus genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 65-67. |
[7] | Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64. |
[8] | Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290. |
[9] | Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294. |
[10] | Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394. |
[12] | Li Jun, Chen XinYue, Zhao Hong, Yu YanYan, Si ChongWen, Han ZhongHou, Zhang WenJin, Chen YuPing, Chen Yong, Wang GuiQiang, Yu Min, Gong WeiBo, Xu JingHang, Wang Jun, Lin XiaoHong, Li XueYing. The relationship of hepatitis B virus genotypes and efficacy of lamivudine and interferon alpha 2b in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2008, 24(3): 169-171. |
[13] | Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106. |
[15] | Liu ChengYong, Hou YuanPei, Qian XiuMei, Sun Qing, Song Li. Distribution of hepatitis B virus genotype in Xuzhou and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(3): 151-152. |
[16] | Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18. |
[17] | Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159. |
[18] | Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76. |
[19] | Lu YinYing, Wang Lin, Liu Yan, Li Ke, Cheng Jun, Zhang LingXia, Li Li. Cloning and expression of gene of hepatitis B virus e antigen in yeast[J]. Journal of Clinical Hepatology, 2003, 19(3): 166-168. |
[20] | Yao Gang, Zhang Lian, Bao LiHua. HBV genotypes and efficacy of interferon-α on patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2002, 18(5): 273-274. |